Injection-site pain after switching from somatrogon to somapacitan in children reporting pain or discomfort during once-weekly growth hormone therapy: a prospective single-arm switch study.
- DOI
- 10.3389/fendo.2026.1849487
- Published
- 2026
- Container
- Frontiers in endocrinology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fendo.2026.1849487,
title = {Injection-site pain after switching from somatrogon to somapacitan in children reporting pain or discomfort during once-weekly growth hormone therapy: a prospective single-arm switch study.},
author = {Iwayama H and Kawahara K and Kitagawa S and Miyamoto R and Takagi J and Ito Y and Okumura A},
year = {2026},
journal = {Frontiers in endocrinology},
doi = {10.3389/fendo.2026.1849487},
url = {https://doi.org/10.3389/fendo.2026.1849487}
}RIS
TY - JOUR TI - Injection-site pain after switching from somatrogon to somapacitan in children reporting pain or discomfort during once-weekly growth hormone therapy: a prospective single-arm switch study. AU - Iwayama H AU - Kawahara K AU - Kitagawa S AU - Miyamoto R AU - Takagi J AU - Ito Y AU - Okumura A PY - 2026 JO - Frontiers in endocrinology DO - 10.3389/fendo.2026.1849487 UR - https://doi.org/10.3389/fendo.2026.1849487 ER -
APA
H, I., K, K., S, K., R, M., J, T., Y, I., & A, O. (2026). Injection-site pain after switching from somatrogon to somapacitan in children reporting pain or discomfort during once-weekly growth hormone therapy: a prospective single-arm switch study.. Frontiers in endocrinology. https://doi.org/10.3389/fendo.2026.1849487
Source records
- pubmed · retrieved 2026-09-25T21:40:29.346Z
- europe-pmc · retrieved 2026-09-25T21:40:29.354Z
- doaj · retrieved 2026-09-25T21:40:29.364Z